Viewing Study NCT04444193


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-27 @ 7:29 AM
Study NCT ID: NCT04444193
Status: UNKNOWN
Last Update Posted: 2020-06-23
First Post: 2020-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma
Sponsor: Shanghai First Maternity and Infant Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module